We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXN icon
51
Texas Instruments
TXN
$243B
$26.3M 0.27%
135,278
-23,486
-15% -$4.34M
PGR icon
52
Progressive
PGR
$126B
$26.3M 0.27%
126,420
-6,232
-5% -$1.3M
VZ icon
53
Verizon
VZ
$205B
$26.2M 0.27%
635,058
+153
+0% +$6.17K
DIS icon
54
Walt Disney
DIS
$184B
$25.9M 0.26%
260,587
-5,238
-2% -$564K
ABT icon
55
Abbott
ABT
$193B
$24.9M 0.25%
239,511
-11,115
-4% -$1.18M
PFE icon
56
Pfizer
PFE
$160B
$24.9M 0.25%
888,632
-50,202
-5% -$1.38M
PANW icon
57
Palo Alto Networks
PANW
$312B
$24.6M 0.25%
145,230
+2,308
+2% +$345K
TJX icon
58
TJX Companies
TJX
$148B
$24.5M 0.25%
222,616
-48,565
-18% -$4.89M
CDNS icon
59
Cadence Design Systems
CDNS
$95.7B
$24.1M 0.25%
78,468
+4,421
+6% +$1.31M
DHR icon
60
Danaher
DHR
$152B
$24M 0.25%
96,194
-876
-0.9% -$221K
GS icon
61
Goldman Sachs
GS
$303B
$23.9M 0.24%
52,845
-796
-1% -$349K
ELV icon
62
Elevance Health
ELV
$86.6B
$23.8M 0.24%
44,012
-168
-0.4% -$88.8K
SNPS icon
63
Synopsys
SNPS
$89B
$23.8M 0.24%
39,990
+396
+1% +$224K
CAT icon
64
Caterpillar
CAT
$376B
$23.3M 0.24%
69,862
-30,958
-31% -$10.7M
AXP icon
65
American Express
AXP
$226B
$23.2M 0.24%
100,194
+686
+0.7% +$159K
ADP icon
66
Automatic Data Processing
ADP
$113B
$22.9M 0.23%
95,896
+1,942
+2% +$477K
VRTX icon
67
Vertex Pharmaceuticals
VRTX
$139B
$22.4M 0.23%
47,695
-11,371
-19% -$4.94M
IBM icon
68
IBM
IBM
$225B
$22.2M 0.23%
128,385
-694
-0.5% -$121K
AMT icon
69
American Tower
AMT
$81.2B
$22.2M 0.23%
113,981
-1,058
-0.9% -$198K
ANET icon
70
Arista Networks
ANET
$254B
$22.1M 0.23%
251,860
+19,440
+8% +$1.45M
MRSH
71
Marsh
MRSH
$90.7B
$22M 0.22%
104,208
-31,711
-23% -$6.51M
MCO icon
72
Moody's
MCO
$88.2B
$21.9M 0.22%
51,989
+905
+2% +$360K
CMCSA icon
73
Comcast
CMCSA
$93.7B
$21M 0.22%
537,406
-9,967
-2% -$390K
SBUX icon
74
Starbucks
SBUX
$122B
$20.6M 0.21%
264,970
+1,735
+0.7% +$141K
MU icon
75
Micron Technology
MU
$1.06T
$20.5M 0.21%
156,197
+427
+0.3% +$53.8K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.